EBioMedicine (Aug 2015)

Astroglial Control of the Antidepressant-Like Effects of Prefrontal Cortex Deep Brain Stimulation

  • A. Etiévant,
  • C. Oosterhof,
  • C. Bétry,
  • E. Abrial,
  • M. Novo-Perez,
  • R. Rovera,
  • H. Scarna,
  • C. Devader,
  • J. Mazella,
  • G. Wegener,
  • C. Sánchez,
  • O. Dkhissi-Benyahya,
  • C. Gronfier,
  • V. Coizet,
  • J.M. Beaulieu,
  • P. Blier,
  • G. Lucas,
  • N. Haddjeri

DOI
https://doi.org/10.1016/j.ebiom.2015.06.023
Journal volume & issue
Vol. 2, no. 8
pp. 898 – 908

Abstract

Read online

Although deep brain stimulation (DBS) shows promising efficacy as a therapy for intractable depression, the neurobiological bases underlying its therapeutic action remain largely unknown. The present study was aimed at characterizing the effects of infralimbic prefrontal cortex (IL-PFC) DBS on several pre-clinical markers of the antidepressant-like response and at investigating putative non-neuronal mechanism underlying DBS action. We found that DBS induced an antidepressant-like response that was prevented by IL-PFC neuronal lesion and by adenosine A1 receptor antagonists including caffeine. Moreover, high frequency DBS induced a rapid increase of hippocampal mitosis and reversed the effects of stress on hippocampal synaptic metaplasticity. In addition, DBS increased spontaneous IL-PFC low-frequency oscillations and both raphe 5-HT firing activity and synaptogenesis. Unambiguously, a local glial lesion counteracted all these neurobiological effects of DBS. Further in vivo electrophysiological results revealed that this astrocytic modulation of DBS involved adenosine A1 receptors and K+ buffering system. Finally, a glial lesion within the site of stimulation failed to counteract the beneficial effects of low frequency (30 Hz) DBS. It is proposed that an unaltered neuronal–glial system constitutes a major prerequisite to optimize antidepressant DBS efficacy. It is also suggested that decreasing frequency could heighten antidepressant response of partial responders.

Keywords